Claria Medical
- Industry
- Medical Equipment Manufacturing
- Founded Year
- 2017
- Headquarters
- San Francisco, California, United States
- Employee Count
- 6
Key People
- Alexey Salamini - Co-Founder and CEO
- Daniel Francis - Chief Technology Officer
- Mira Sahney - President and CEO
- Brian Fisher - Leader in Regulatory, Quality, Clinical and Operations
- Joe Jones - Chief Medical Advisor
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises individuals with over a decade of experience in the medical device industry.
The presence of seasoned professionals in key roles suggests a strong foundation for strategic decision-making and product development.
- Clinical Need
-
Aspect: Very Strong
Summary: Claria Medical addresses significant unmet needs in women's healthcare, particularly in minimally invasive gynecologic surgeries.
By developing safer and more efficient surgical tools, Claria Medical is positioned to make a substantial impact in women's health.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for minimally invasive surgical tools in gynecology has several players, but Claria Medical's unique approach offers differentiation.
The company's focus on addressing specific unmet needs and obtaining FDA designations can help it stand out in a crowded market.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing minimally invasive surgical tools involves moderate technical challenges, which Claria Medical is equipped to handle.
With a strong R&D focus and experienced personnel, Claria Medical is well-prepared to overcome technical hurdles in product development.
- Patent
-
Aspect: Strong
Summary: Claria Medical has a robust patent portfolio, enhancing its competitive position.
A strong patent portfolio can deter competitors and attract potential investors or partners, contributing to the company's success.
- Financing
-
Aspect: Medium
Summary: Claria Medical has secured moderate funding through grants and private investments.
The company's current financial resources support ongoing R&D but may require further investment to scale operations and market entry.
- Regulatory
-
Aspect: 510k/PMA
Summary: Claria Medical has received a 'Safer Technologies Designation' from the FDA, indicating a favorable regulatory pathway.
Achieving this designation suggests that Claria Medical's products meet high safety standards, potentially expediting market entry.
Opportunity Rollup
- Odds of Success
- 3.85
- Peak Market Share
- 5.2
- Segment CAGR
- 10.7%
- Market Segment
- Medical Devices
- Market Sub Segment
- Minimally Invasive Gynecologic Surgical Tools
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.26 |
| 2 | 0.78 |
| 3 | 1.82 |
| 4 | 3.64 |
| 5 | 5.20 |
Key Takeaway
Claria Medical is well-positioned to address significant unmet needs in women's healthcare with its innovative minimally invasive surgical tools, supported by a strong team and favorable regulatory designations.